BRIEF-AstraZeneca Says Enhertu Approved In The EU For Breast Cancer

AstraZeneca PLC: * ASTRAZENECA PLC - ENHERTU APPROVED IN THE EU FOR BREAST CANCER

ASTRAZENECA - ENHERTU APPROVAL BASED ON DESTINY-BREAST01 PHASE II TRIAL * ASTRAZENECA - FOLLOWING EU APPROVAL, $75M IS DUE FROM ASTRAZENECA TO DAIICHI SANKYO AS A MILESTONE PAYMENT FOR HER2-POSITIVE BREAST CANCER Source text for Eikon: Further company coverage:

(This story has not been edited by Devdiscourse staff and is auto-generated from a syndicated feed.)